AI in Pharma and Biotech Market
Buy Now Request Sample Explore
Home › Report Store › Life Sciences  › AI in Pharma and Biotech Market

AI in Pharma and Biotech Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The AI in Pharma and Biotech Market size was valued at US$ 6.43 Billion in 2025 and is projected to reach US$ 122.32 Billion by 2033, growing at a CAGR of 44.51% during 2026–2033, driven by accelerated drug discovery, rising clinical trial complexity, expanding multimodal datasets, precision medicine adoption, and increasing strategic partnerships between pharmaceutical companies and AI technology providers.

Report Coverage
  • Technology: Machine Learning & Deep Learning, Natural Language Processing
  • Application: Drug Discovery & Development, Clinical Research & Optimization, Precision Medicine, Pharmaceutical Manufacturing, Operations & Medical Affairs
  • End User: Pharmaceutical & Biotechnology Companies, CDMOs & CROs
US$ 6.43 Bn Market size in 2025
US$ 122.32 Bn Market Size by 2033
44.51% CAGR, 2026 - 2033
2026-2033 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. AI in Pharma and Biotech Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. AI in Pharma and Biotech Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. AI in Pharma and Biotech Market Global Analysis

6.2 AI in Pharma and Biotech Market Revenue 2022-2033 (US$ Billion)
6.3 AI in Pharma and Biotech Market Forecast Analysis

7. AI in Pharma and Biotech Market Analysis – by Technology

7.1 Machine Learning & Deep Learning
  • 7.1.1 Overview
  • 7.1.2 Machine Learning & Deep Learning: AI in Pharma and Biotech Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.2 Natural Language Processing
  • 7.2.1 Overview
  • 7.2.2 Natural Language Processing: AI in Pharma and Biotech Market – Revenue and Forecast, 2022-2033 (US$ Billion)

8. AI in Pharma and Biotech Market Analysis – by Application

8.1 Drug Discovery & Development
  • 8.1.1 Overview
  • 8.1.2 Drug Discovery & Development: AI in Pharma and Biotech Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.2 Clinical Research & Optimization
  • 8.2.1 Overview
  • 8.2.2 Clinical Research & Optimization: AI in Pharma and Biotech Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.3 Precision Medicine
  • 8.3.1 Overview
  • 8.3.2 Precision Medicine: AI in Pharma and Biotech Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.4 Pharmaceutical Manufacturing
  • 8.4.1 Overview
  • 8.4.2 Pharmaceutical Manufacturing: AI in Pharma and Biotech Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.5 Operations & Medical Affairs
  • 8.5.1 Overview
  • 8.5.2 Operations & Medical Affairs: AI in Pharma and Biotech Market – Revenue and Forecast, 2022-2033 (US$ Billion)

9. AI in Pharma and Biotech Market Analysis – by End User

9.1 Pharmaceutical & Biotechnology Companies
  • 9.1.1 Overview
  • 9.1.2 Pharmaceutical & Biotechnology Companies: AI in Pharma and Biotech Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9.2 CDMOs & CROs
  • 9.2.1 Overview
  • 9.2.2 CDMOs & CROs: AI in Pharma and Biotech Market – Revenue and Forecast, 2022-2033 (US$ Billion)

10. AI in Pharma and Biotech Market – Geographic Analysis

10.1 Overview

10.2 North America
  • 10.2.1 AI in Pharma and Biotech Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.2.1.1 AI in Pharma and Biotech Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 US: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.2.1.1.1 US: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.2.1.1.2 US: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.2.1.1.3 US: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.2.1.2 Canada: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.2.1.2.1 Canada: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.2.1.2.2 Canada: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.2.1.2.3 Canada: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.2.1.3 Mexico : AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.2.1.3.1 Mexico : AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.2.1.3.2 Mexico : AI in Pharma and Biotech Market Breakdown, by Application
    • 10.2.1.3.3 Mexico : AI in Pharma and Biotech Market Breakdown, by End User
10.3 Europe
  • 10.3.1 AI in Pharma and Biotech Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.3.1.1 AI in Pharma and Biotech Market – Revenue and Forecast Analysis – by Country
  • 10.3.1.1 Germany: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.1.1 Germany: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.1.2 Germany: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.1.3 Germany: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.2 Italy: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.2.1 Italy: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.2.2 Italy: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.2.3 Italy: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.3 France: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.3.1 France: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.3.2 France: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.3.3 France: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.4 U.K.: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.4.1 U.K.: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.4.2 U.K.: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.4.3 U.K.: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.5 Spain: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.5.1 Spain: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.5.2 Spain: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.5.3 Spain: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.6 Belgium: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.6.1 Belgium: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.6.2 Belgium: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.6.3 Belgium: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.7 Netherlands: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.7.1 Netherlands: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.7.2 Netherlands: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.7.3 Netherlands: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.8 Luxembourg: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.8.1 Luxembourg: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.8.2 Luxembourg: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.8.3 Luxembourg: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.9 Norway: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.9.1 Norway: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.9.2 Norway: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.9.3 Norway: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.10 Finland: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.10.1 Finland: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.10.2 Finland: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.10.3 Finland: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.11 Denmark: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.11.1 Denmark: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.11.2 Denmark: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.11.3 Denmark: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.12 Sweden: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.12.1 Sweden: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.12.2 Sweden: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.12.3 Sweden: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.13 Switzerland: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.13.1 Switzerland: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.13.2 Switzerland: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.13.3 Switzerland: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.14 Austria: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.14.1 Austria: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.14.2 Austria: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.14.3 Austria: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.15 Greece: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.15.1 Greece: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.15.2 Greece: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.15.3 Greece: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.16 Portugal: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.16.1 Portugal: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.16.2 Portugal: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.16.3 Portugal: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.17 Russia: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.17.1 Russia: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.17.2 Russia: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.17.3 Russia: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.18 Poland: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.18.1 Poland: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.18.2 Poland: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.18.3 Poland: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.19 Romania: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.19.1 Romania: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.19.2 Romania: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.19.3 Romania: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.20 Czech Republic: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.20.1 Czech Republic: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.20.2 Czech Republic: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.20.3 Czech Republic: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.21 Ukraine: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.21.1 Ukraine: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.21.2 Ukraine: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.21.3 Ukraine: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.22 Slovakia: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.22.1 Slovakia: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.22.2 Slovakia: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.22.3 Slovakia: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.3.1.23 Bulgaria : AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.3.1.23.1 Bulgaria : AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.3.1.23.2 Bulgaria : AI in Pharma and Biotech Market Breakdown, by Application
    • 10.3.1.23.3 Bulgaria : AI in Pharma and Biotech Market Breakdown, by End User
10.4 Asia-Pacific
  • 10.4.1 AI in Pharma and Biotech Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.4.1.1 AI in Pharma and Biotech Market – Revenue and Forecast Analysis – by Country
  • 10.4.1.1 China: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.1.1 China: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.1.2 China: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.1.3 China: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.2 Japan: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.2.1 Japan: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.2.2 Japan: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.2.3 Japan: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.3 South Korea: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.3.1 South Korea: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.3.2 South Korea: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.3.3 South Korea: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.4 India: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.4.1 India: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.4.2 India: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.4.3 India: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.5 Australia: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.5.1 Australia: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.5.2 Australia: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.5.3 Australia: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.6 New Zealand: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.6.1 New Zealand: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.6.2 New Zealand: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.6.3 New Zealand: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.7 Indonesia: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.7.1 Indonesia: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.7.2 Indonesia: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.7.3 Indonesia: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.8 Malaysia: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.8.1 Malaysia: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.8.2 Malaysia: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.8.3 Malaysia: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.9 Philippines: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.9.1 Philippines: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.9.2 Philippines: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.9.3 Philippines: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.10 Singapore: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.10.1 Singapore: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.10.2 Singapore: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.10.3 Singapore: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.11 Thailand: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.11.1 Thailand: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.11.2 Thailand: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.11.3 Thailand: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.12 Vietnam: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.12.1 Vietnam: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.12.2 Vietnam: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.12.3 Vietnam: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.13 Taiwan: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.13.1 Taiwan: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.13.2 Taiwan: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.13.3 Taiwan: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.4.1.14 Bangladesh : AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.4.1.14.1 Bangladesh : AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.4.1.14.2 Bangladesh : AI in Pharma and Biotech Market Breakdown, by Application
    • 10.4.1.14.3 Bangladesh : AI in Pharma and Biotech Market Breakdown, by End User
10.5 South and Central America
  • 10.5.1 AI in Pharma and Biotech Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.5.1.1 AI in Pharma and Biotech Market – Revenue and Forecast Analysis – by Country
  • 10.5.1.1 Brazil: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.1.1 Brazil: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.5.1.1.2 Brazil: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.5.1.1.3 Brazil: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.5.1.2 Argentina: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.2.1 Argentina: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.5.1.2.2 Argentina: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.5.1.2.3 Argentina: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.5.1.3 Chile: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.3.1 Chile: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.5.1.3.2 Chile: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.5.1.3.3 Chile: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.5.1.4 Colombia: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.4.1 Colombia: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.5.1.4.2 Colombia: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.5.1.4.3 Colombia: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.5.1.5 Peru : AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.5.1.5.1 Peru : AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.5.1.5.2 Peru : AI in Pharma and Biotech Market Breakdown, by Application
    • 10.5.1.5.3 Peru : AI in Pharma and Biotech Market Breakdown, by End User
10.6 Middle East and Africa
  • 10.6.1 AI in Pharma and Biotech Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.6.1.1 AI in Pharma and Biotech Market – Revenue and Forecast Analysis – by Country
  • 10.6.1.1 Saudi Arabia: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.1.1 Saudi Arabia: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.1.2 Saudi Arabia: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.1.3 Saudi Arabia: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.2 United Arab Emirates: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.2.1 United Arab Emirates: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.2.2 United Arab Emirates: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.2.3 United Arab Emirates: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.3 Kuwait: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.3.1 Kuwait: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.3.2 Kuwait: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.3.3 Kuwait: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.4 Bahrain: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.4.1 Bahrain: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.4.2 Bahrain: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.4.3 Bahrain: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.5 Qatar: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.5.1 Qatar: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.5.2 Qatar: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.5.3 Qatar: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.6 Oman: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.6.1 Oman: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.6.2 Oman: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.6.3 Oman: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.7 Turkiye: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.7.1 Turkiye: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.7.2 Turkiye: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.7.3 Turkiye: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.8 South Africa: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.8.1 South Africa: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.8.2 South Africa: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.8.3 South Africa: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.9 Egypt: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.9.1 Egypt: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.9.2 Egypt: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.9.3 Egypt: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.10 Nigeria: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.10.1 Nigeria: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.10.2 Nigeria: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.10.3 Nigeria: AI in Pharma and Biotech Market Breakdown, by End User
  • 10.6.1.11 Algeria: AI in Pharma and Biotech Market – Revenue and Forecast to 2033 (US$ Billion)
    • 10.6.1.11.1 Algeria: AI in Pharma and Biotech Market Breakdown, by Technology
    • 10.6.1.11.2 Algeria: AI in Pharma and Biotech Market Breakdown, by Application
    • 10.6.1.11.3 Algeria: AI in Pharma and Biotech Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 NVIDIA Corporation
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Microsoft Corporation
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Alphabet Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Amazon.com, Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 IQVIA Holdings Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Recursion Pharmaceuticals, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Exscientia plc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Insilico Medicine
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Schrodinger, Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Tempus AI, Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

Access the Full A Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization
Access the full A Market Report
350 pages PDF & Excel | 2026-08-31
Download Sample Customization